LUCD

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Lucid Diagnostics Inc

NASDAQ | LUCD

1.15

USD

(

+0.00%

)

At Close (As of Jan 1, 1970)

$149.45M

Market Cap

-

P/E Ratio

-0.77

EPS

$1.80

52 Week High

$0.75

52 Week Low

HEALTHCARE

Sector

LUCD Chart

Recent Chart
Price Action

LUCD Technicals

Tags:

LUCD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$3.9M
Total Revenue $4.3M
Cost Of Revenue $8.3M
Costof Goods And Services Sold $8.3M
Operating Income -$46M
Selling General And Administrative $20B
Research And Development $6M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $296K
Interest Income $322K
Interest Expense $26K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$46M
Income Tax Expense $7.5B
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$44M
Net Income -$46M

Revenue & Profitability

LUCD Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $31M
Total Current Assets $25M
Cash And Cash Equivalents At Carrying Value $22M
Cash And Short Term Investments $22M
Inventory $341K
Current Net Receivables $405K
Total Non Current Assets $5.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $736K
Intangible Assets Excluding Goodwill $736K
Goodwill $735M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2M
Other Non Current Assets -
Total Liabilities $25M
Total Current Liabilities $24M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt $19M
Total Non Current Liabilities $1.8M
Capital Lease Obligations $2.7M
Long Term Debt -
Current Long Term Debt $19M
Long Term Debt Noncurrent -
Short Long Term Debt Total $21M
Other Current Liabilities $2.8M
Other Non Current Liabilities -
Total Shareholder Equity $5.4M
Treasury Stock -
Retained Earnings -$204M
Common Stock $63K
Common Stock Shares Outstanding $51M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$44M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.2M
Capital Expenditures $646K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$646K
Cashflow From Financing $48M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $447M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$46M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$3.9M
Total Revenue $4.3M
Cost Of Revenue $8.3M
Costof Goods And Services Sold $8.3M
Operating Income -$46M
Selling General And Administrative $20B
Research And Development $6M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $296K
Interest Income $322K
Interest Expense $26K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$46M
Income Tax Expense $7.5B
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$44M
Net Income -$46M

LUCD Profile

Lucid Diagnostics Inc Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Lucid Diagnostics Inc. is a pioneering medical diagnostic technology company based in New York, focused on revolutionizing early cancer detection and improving patient care. The company leverages cutting-edge technologies to develop innovative diagnostic tests that support informed clinical decision-making and enhance patient outcomes within the oncology field. With its dedication to addressing significant unmet needs in healthcare, Lucid Diagnostics is strategically positioned to be a vital player in the evolving medical diagnostics landscape, driving advancements that could reshape treatment methodologies and improve the quality of care for patients facing cancer.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+91.75%
$1.21
OCG
-75.85%
$0.22
NVDA
-3.26%
$175.02
CGC
+51.33%
$1.71
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.30%
$457.20
INTC
-4.30%
$37.81
ONDS
-1.82%
$8.85
TLRY
+43.90%
$12.13
ATPC
-25.11%
$0.13
AVGO
-12.32%
$356.27
KIND
+9.48%
$2.77
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-35.55%
$0.12
ORCL
-4.60%
$189.69
SOFI
+0.77%
$27.28
TE
-8.94%
$5.34
VIVK
-1.75%
$0.07
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
F
+0.88%
$13.75
PLTD
+2.29%
$6.46
AAL
0.00%
$14.96
HPE
-2.68%
$23.88
KVUE
-0.02%
$17.31
SOND
-23.45%
$0.12
MARA
-2.70%
$11.52
PLTR
-2.11%
$183.57
VALE
-4.43%
$12.70
BAC
+1.11%
$55.17
RMBL
+60.50%
$3.21
RR
-11.85%
$4.12
BMNR
-8.59%
$35.08
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
BMNU
-18.10%
$8.36
SNAP
-4.38%
$7.30
CLSK
-5.33%
$14.03
DNN
-5.06%
$2.62
APLT
-45.91%
$0.11
ACHR
-2.27%
$8.36
IREN
-8.67%
$40.13
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
IRBT
-14.60%
$4.27
GOOGL
-1.00%
$309.29
NIO
-2.04%
$5.02
CIFR
-9.69%
$17.05
NFLX
+1.72%
$95.71
ASBP
-5.64%
$0.09
AMD
-4.89%
$210.59
RKLB
-3.05%
$61.59
GRAB
-0.57%
$5.15
BBD
+1.46%
$3.46
CRWV
-8.43%
$80.00
BITF
-4.59%
$2.80
MTSR
-0.35%
$70.50
AMZN
-1.81%
$226.09
FI
+2.38%
$68.16
ABEV
+1.80%
$2.54
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
JBLU
+1.02%
$4.94
AAPL
-0.15%
$277.59
HL
-2.76%
$18.81
CHR
0.00%
$0.04
QBTS
-2.99%
$27.14
APLD
-9.42%
$27.86
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
CDE
-1.31%
$17.25
BTG
-1.07%
$4.62
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
AG
-5.37%
$15.90
IVP
-9.22%
$0.04
BTBT
-8.22%
$2.25
NOK
-1.49%
$6.26
SMR
-10.50%
$18.99
EOSE
-9.73%
$14.84
TWOH
0.00%
$0.00
KPLT
+17.96%
$7.32
GOOG
-1.01%
$310.52
LUV
+1.08%
$41.18
GRYP
-10.38%
$1.38
TSM
-4.16%
$292.14
BMY
+2.40%
$52.43
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+91.75%
$1.21
OCG
-75.85%
$0.22
NVDA
-3.26%
$175.02
CGC
+51.33%
$1.71
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.30%
$457.20
INTC
-4.30%
$37.81
ONDS
-1.82%
$8.85
TLRY
+43.90%
$12.13
ATPC
-25.11%
$0.13
AVGO
-12.32%
$356.27
KIND
+9.48%
$2.77
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-35.55%
$0.12
ORCL
-4.60%
$189.69
SOFI
+0.77%
$27.28
TE
-8.94%
$5.34
VIVK
-1.75%
$0.07
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
F
+0.88%
$13.75
PLTD
+2.29%
$6.46
AAL
0.00%
$14.96
HPE
-2.68%
$23.88
KVUE
-0.02%
$17.31
SOND
-23.45%
$0.12
MARA
-2.70%
$11.52
PLTR
-2.11%
$183.57
VALE
-4.43%
$12.70
BAC
+1.11%
$55.17
RMBL
+60.50%
$3.21
RR
-11.85%
$4.12
BMNR
-8.59%
$35.08
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
BMNU
-18.10%
$8.36
SNAP
-4.38%
$7.30
CLSK
-5.33%
$14.03
DNN
-5.06%
$2.62
APLT
-45.91%
$0.11
ACHR
-2.27%
$8.36
IREN
-8.67%
$40.13
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
IRBT
-14.60%
$4.27
GOOGL
-1.00%
$309.29
NIO
-2.04%
$5.02
CIFR
-9.69%
$17.05
NFLX
+1.72%
$95.71
ASBP
-5.64%
$0.09
AMD
-4.89%
$210.59
RKLB
-3.05%
$61.59
GRAB
-0.57%
$5.15
BBD
+1.46%
$3.46
CRWV
-8.43%
$80.00
BITF
-4.59%
$2.80
MTSR
-0.35%
$70.50
AMZN
-1.81%
$226.09
FI
+2.38%
$68.16
ABEV
+1.80%
$2.54
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
JBLU
+1.02%
$4.94
AAPL
-0.15%
$277.59
HL
-2.76%
$18.81
CHR
0.00%
$0.04
QBTS
-2.99%
$27.14
APLD
-9.42%
$27.86
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
CDE
-1.31%
$17.25
BTG
-1.07%
$4.62
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
AG
-5.37%
$15.90
IVP
-9.22%
$0.04
BTBT
-8.22%
$2.25
NOK
-1.49%
$6.26
SMR
-10.50%
$18.99
EOSE
-9.73%
$14.84
TWOH
0.00%
$0.00
KPLT
+17.96%
$7.32
GOOG
-1.01%
$310.52
LUV
+1.08%
$41.18
GRYP
-10.38%
$1.38
TSM
-4.16%
$292.14
BMY
+2.40%
$52.43
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.